На главную / Научное направление / Лаборатории / Лаборатория клинических биохимических и гормональных исследований терапевтических заболеваний /

Основные публикации

  1. Polonskaya YV, Kashtanova EV, Murashov IS, Striukova EV, Kurguzov AV, Stakhneva EM, Shramko VS, Maslatsov NA, Chernyavskii AM and Ragino YI Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD. J. Pers. Med. 2021, 11(6), 506-14. DOI: 10.3390/jpm11060506.
  2. Striukova EV,Maksimov VN, Ragino YI, Polonskaya YV,Murashov IS,Volkov AM,Kurguzov AV, Chernyavskii AM, Kashtanova EV.Polymorphisms in the CETP, APOC3 and APOE genes in men with unstable atherosclerotic plaques in the coronary arteries.META GENE.2021. 27:100847.DOI: 10.1016/j.mgene.2020.100847.
  3. Ragino YI, Striukova EV, Murashov IS, Polonskaya YV, Volkov AM, Kurguzov AV, Chernjavskii AM, Kashtanova EV. Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. BMC Res Notes. 2019;12(1):336. DOI: 10.1186/s13104-019-4360-7.
  4. Polonskaya YV, Kashtanova EV, Murashov IS, Kurguzov AV, Sadovski EV, Maslatsov NA, Stakhneva EM, Chernyavskii AM and Ragino YI The influence of calcification factors and endothelial-dysfunction factors on the development of unstable atherosclerotic plaques. Diagnostics, 2020, 10(12), 1074. DOI: 10.3390/diagnostics10121074.
  5. Kashtanova E.V.,PolonskayaYa.V., RaginoYu.I. Calcification and atherosclerosis of the coronary arteries. Terapevticheskiiarkhiv. 2021. 93(1):84-86. DOI: 10.26442/00403660.2021.01.200598.
  6. Ragino YI, Shcherbakova LV, Oblaukhova VI, Polonskaya YV,Stakhneva EM,Kuz'minykh, NA, Kashtanova E.V. Blood Adipokins in Young People with Early Ischemic Heart Disease on the Background of Abdominal Obesity. Kardiologiya. 2021. 61(4):32-38. DOI: 10.18087/cardio.2021.4.n1369.
  7. Shramko VS, Polonskaya YV, Kashtanova EV, Stakhneva EM, Ragino YI. The Short Overview on the Relevance of Fatty Acids for Human Cardiovascular Disorders. Biomolecules 2020, 10(8), 1127. DOI: 10.3390/biom10081127.
  8. Ragino YI, Oblaukhova VI,Polonskaya YV, Kuz'minykh, NA, Shcherbakova LV, Kashtanova EV.The Blood Cytokine Profile of Young People with Early Ischemic Heart Disease Comorbid with Abdominal Obesity. J. Pers. Med. 2021, 10(3):87. DOI: 10.3390/jpm10030087.
  9. Ragino YI; Stakhneva EM; Polonskaya YV; Kashtanova EV The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review. Biomolecules 2020, 10(3), 374-392. DOI:10.3390/biom10030374.
  10. Stakhneva EM, Meshcheryakova IA, Demidov EA, Starostin KV, Peltek SE, Voevoda MI, Ragino YI Changes in the proteomic profile of blood serum in coronary atherosclerosis. J Med Biochem, 2020, 39(2):208-214. DOI: 10.2478/jomb-2019-0022.
  11. RaginoYuI, Shramko VS, Stakhneva EM, Chernyak EI, Morozov SV, ShakhtshneiderEV,Polonskaya YV, Shcherbakova LV, Chernyavski АМ. Changes in the blood fatty-acid profile associated with oxidative-antioxidant disturbances in coronary atherosclerosis. J Med Biochem, 2020, 39(1): 46-53. DOI: 10.2478/jomb-2019-0010.
  12. Stakhneva EM, Meshcheryakova IA, Demidov EA, Starostin KV, Sadovski EV, Peltek SE, Voevoda MI, Chernyavskii AM, Volkov AM, RaginoYuI. A Proteomic Study of Atherosclerotic Plaques in Men with Coronary Atherosclerosis. Diagnostics, 2019, 9(4), E177. DOI: 10.3390/diagnostics9040177.
  13. Shramko VS, Polonskaya YV, Morozov SV, Chernyak EI, Chernyavsky AM, Ragino YI.Polyunsaturated Fatty Acids and Their Correlations with Parameters of Oxidative/Antioxidant Potential of the Blood and Lipoprotein-Associated Phospholipase A2 in Coronary Atherosclerosis. Bull ExpBiol Med.2018. 166(1):11-14. DOI: 10.1007/s10517-018-4277-5.
  14. Polonskaya YV, Shramko VS, Morozov SV, Chernyak EI, Chernyavsky AM, Ragino YI.Balance of Fatty Acids and Their Correlations with Parameters of Lipid Metabolism and Markers of Inflammation in Men with Coronary Atherosclerosis. Bull ExpBiol Med. 2017. 164(1):33-35. DOI: 10.1007/s10517-017-3920-x.
  15. Ragino YI,Astrakova KS, Shakhtshneider EV, Stakhneva EM, Gafarov VV, Bogatyrev SN, Voevoda MI. Blood Levels of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Men from Different Population Groups and Its Relation to Unfavorable Long-Term Prognosis. Kardiologiia. 2017;57(4):72-76. DOI: 10.18565/cardio.2017.4.72-76.
  16. Benimetskaya KS, RaginoYuI, Shakhtshneider EV, Makarenkova KV, ShchepinaYuV, Stakhneva EM, Voevoda MI. Association of level of proprotein convertase subtilisin/kexin type 9 with intima-media thickness in patients with familial hypercholesterolemia. Bull ExpBiol Med, 2017, 163(2):160-163.DOI: 10.1007/s10517-017-3765-3.
  17. Stakhneva EM, Meshcheryakova IA, Demidov EA, Starostin KV, Ragino YI, Peltek SE, Voevoda MI Proteomic Study of Blood Serum in Coronary Atherosclerosis. Bull ExpBiol Med, 2017, 162(3):343-345. DOI: 10.1007/s10517-017-3611-7.
  18. Zhuravskaya EY, Savchenko TI, Chankina OV, PolonskayaYaV, Chernyavskii AM, Ragino YI, Scherbakova LV. SRXRF study of chemical elements content in the atherosclerotic plaque of heart vessels. Physics Procedia, 2016, 84:270-274. DOI: 10.1016/j.phpro.2016.11.046.
  19. ЖуравскаяЭ.Я., СавченкоТ.И., Чанкина, О.В. ПолонскаяЯ.В., ЧернявскийА.М., РагиноЮ.И. «Химическиеэлементывстенкахсосудов сердца». Известия РАН. Серия физическая, 2015, 79(1):74-77. DOI: 10.7868/S0367676515010391.
  20. ZhuravskayaEY, GyrgolkauLA, ScherbakovaLV, KoutzenogiiKP, ChankinaOV, SavchenkoTI. Chemical elements and some risk factors for chronic non-infectious diseases in the population of Novosibirsk. Bulletin of the Russian of Sciences, Physics, 2013, 77(2):179-181. DOI: 10.3103/S1062873813020421.
  21. Stakhneva EM, Vavilin VA, RaginoYuI, Safronova OG, Shintyapina AB, Ivanova MV. Effects of Simvaglyzin and Atorvaglyzin on the Expression of 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase in Rat Liver. Bulletin of Experimental Biology and Medicine, 2013, 156(1):63-65. DOI: 10.1007/s10517-013-2278-y.
  22. Ragino YI, Voevoda MI, Malyutina SK, Gafarov VV, Shishkin SV, Bogatyrev SN, Scherbakova LV, Polonskaya YV. The relation of atherogenic oxidative-antioxidant shifts in low density lipoproteides with adverse long-term prognosis in males. Russian Journal of Cardiology. 2016. 21(12):45-48.DOI: 10.15829/1560-4071-2016-12-45-48.
  23. Каштанова Е.В., Чернявский А.М., Полонская Я.В., Стахнёва Е.М., Кургузов А.В., Мурашов И.С., Каменская О.В., Рагино Ю.И. Исследование комплекса биомаркеров в крови у мужчин с коронарным атеросклерозом. Российский кардиологический журнал. 2016. 21(2):60-64.DOI: 10.15829/1560-4071-2016-2-60-64.
  24. Рагино Ю.И., Стахнёва Е.М., Садовский Е.В., Щербакова Л.В., Малютина С.К. Связь окислительных показателей липопротеинов низкой плотности с возрастом в мужской популяции новосибирска. Российский кардиологический журнал. 2016. 21(6):41-44.DOI: 10.15829/1560-4071-2016-6-41-44
  25. RaginoYI, TimoshenkoNA, ChernjavskyiAM, TcimbalSYu, ScherbakovaLV, VoevodaMI. Relationshipofmetabolicsyndromecomponentswithelectrocardiographicbiomarkersofmetaboliccardiomyopathyinmenwithcoronaryatherosclerosis. RussianJournalofCardiology. 2015. 20(4):68-72.DOI: 10.15829/1560-4071-2015-04-68-72.